I feel the problem is everyone was looking for a quick fix, a one and done approach where the World just gets back to normal, no problem. They held off on therapeutics because they are long term, not quick fix. And, if long haulers is any indication, even leronlimab will need to be taken for weeks or months once people get really sick. That's why no side effects is important and that will bode well for us as a company.

But long term, slow therapeutics do not make for good press so you can see how hard they are to get implemented.